This federal contract award, numbered SPE2DB22D1106 and SPE2DB25FDMB3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,379.54 Firm Fixed Price contract is for the delivery of 4566487307 - LIDOCAINE HCL 2% 200 MG/10 ML 10ML. The contract has an ultimate completion date of November 20, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
This contract award was not designated with any set-aside requirements, indicating open competition.
Generated 2/18/25, 1:49 PM